Surgical oncology: Difference between revisions

The importance of training surgeons who sub-specialize in cancer surgery lies in evidence, supported by a number of [[clinical trials]]{{citation needed|reason=Your explanation here|date=November 2014}}, that outcomes in surgical cancer care are positively associated to surgeon volume—i.e., the more [[cancer]] cases a surgeon treats, the more proficient he or she becomes, and his or her patients experience improved survival rates as a result. This is another controversial point, but it is generally accepted—even as common sense—that a surgeon who performs a given operation more often, will achieve superior results when compared with a surgeon who rarely performs the same procedure. This is particularly true of complex cancer resections such as [[pancreaticoduodenectomy]] (Whipple procedure) for pancreatic cancer, and [[gastrectomy]] with extended (D2) [[lymphadenectomy]] for gastric cancer. In the United States and Canada, fellowship trained surgical oncologists have among the longest training periods of any physicians/surgeons. A training period (clinical and research) of 6 to 8 years is typical and 8–10 years is not uncommon.